Questions?
Let’s connect.



    BIOCAT, THE BIOREGION OF CATALONIA, as the data controller, will process your data in order to respond to your inquiry or request. You can access, rectify, and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Privacy policy.







    Send

    Connecting knowledge, people and ideas to advance health innovation

    • Events
    • News
    • Interviews

    Events

    ATMP Day 2026
    10.09.2026 CaixaForum

    ATMP Day 2026
    Know more
    More info
    Advanced Therapies Europe
    07.09.2026 09.09.2026 Barcelona

    Advanced Therapies Europe
    Know more
    More info

    News

    25.06.26

    SJD Barcelona has been awarded European MIA accreditation to produce advanced therapies for other centres

    Read more
    11.06.26

    Six projects join the second ATMP Catalyst call to advance advanced therapies in Catalonia

    Read more
    29.04.26

    Inside the CAR-T kitchens, the innovative cancer immunotherapy: “It’s a revolution”

    Read more
    17.04.26

    UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science

    Read more
    05.04.26

    A Catalan hospital consortium takes on the deadliest pediatric tumor with its CAR-T

    Read more
    13.04.26

    PRECISEU launches €11.57 million call for proposals for innovation projects in personalized medicine

    Read more
    16.03.26

    ATMP Catalyst opens second call to accelerate new advanced therapies projects in Catalonia

    Read more
    10.02.26

    Gyala Therapeutics initiates Phase I/IIa clinical trial of a CAR-T cell therapy for acute leukemias with limited treatment options

    Read more
    26.01.26

    ATMP Catalonia launches new identity and website to strengthen its international positioning

    Read more
    06.11.25

    SpliceBio has closed a €119M financing round, the largest for a biotech company in Spain

    Read more
    29.10.25

    Hospital del Mar Research Institute and the Blood and Tissue Bank are launching a new program on Cellular Therapy and Substances of Human Origin (SoHo)

    Read more
    18.09.25

    Catalonia takes centre stage at the PRECISEU Best Practice Recognition 2025

    Read more
    18.09.25

    Hipra will invest €500M in a new biotechnology hub that will create more than 1,000 jobs

    Read more
    09.08.25

    Integra Therapeutics raises €10.7M to advance its FiCAT gene writing platform

    Read more
    27.05.25

    Theriva Biologics has announced the primary efficacy and safety results from its phase 2b VIRAGE study

    Read more
    29.04.25

    The new CAR-T therapy at Hospital de Sant Pau for the treatment of lymphoma has achieved positive results in a high proportion of refractory patients

    Read more
    17.03.25

    EsoBiotec, a startup backed by Invivo Ventures, has announced a $1B acquisition agreement with AstraZeneca, strengthening the international presence and recognition of Catalonia’s entrepreneurial ecosystem

    Read more
    13.03.25

    SpliceBio has dosed the first patient in its Astra clinical trial with a gene therapy for inherited retinal diseases

    Read more
    13.02.25

    OneChain ImmunoTherapeutics has been selected by the support unit of the Innovation Adoption in the Health System Program (PASS)

    Read more
    17.02.25

    Biocat presents the 2024 BioRegion Report

    Read more
    04.02.25

    Clínic-IDIBAPS presents results from the first 500 patients treated with CAR-T therapies and outlines future projects in this field

    Read more

    Interviews

    https://atmpcatalonia.com/wp-content/uploads/2026/07/Joaquin-Arribas-Hospital-del-Mar.jpg
    Dr. Joaquín Arribas Data Hospital del Mar Research Institute 23.07.2026

    “In recent years, we have demonstrated that it is possible to take developments originating in academia all the way to clinical trials.”

    Read more